GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of DCPH
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Weaker technical forecast for Deciphera Pharmaceuticals Inc as stock downgraded to Sell Candidate.
(Updated on Apr 18, 2024)

Sell candidate since Apr 18, 2024 PDF

The Deciphera Pharmaceuticals Inc stock price fell by -3.33% on the last day (Thursday, 18th Apr 2024) from $14.72 to $14.23. It has now fallen 7 days in a row. During the last trading day the stock fluctuated 5.07% from a day low at $14.19 to a day high of $14.91. The price has fallen in 8 of the last 10 days and is down by -6.01% for this period. Volume has increased on the last day by 465 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 743 thousand shares were bought and sold for approximately $10.57 million.

Given the current short-term trend, the stock is expected to rise 4.61% during the next 3 months and, with a 90% probability hold a price between $14.89 and $18.60 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

DCPH Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Deciphera Pharmaceuticals Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $14.98 and $15.66. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 01, 2024, and so far it has fallen -18.03%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Deciphera Pharmaceuticals Inc stock

Deciphera Pharmaceuticals Inc finds support from accumulated volume at $14.17 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.720 (5.07%) between high and low. For the last week, the stock has had daily average volatility of 3.66%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (DCPH) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Deciphera Pharmaceuticals Inc to open at $14.44, and during the day (based on 14 day Average True Range), to move between $13.61 and $14.85, which gives a possible trading interval of +/-$0.624 (+/-4.39%) up or down from last closing price. If Deciphera Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 8.77% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $14.17 (0.42%) than the resistance at $14.39 (1.12%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Deciphera Pharmaceuticals Inc stock A Buy?

The Deciphera Pharmaceuticals Inc stock holds several negative signals and despite the positive trend, we believe Deciphera Pharmaceuticals Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -2.071 Sell Candidate Downgraded

Predicted Opening Price for Deciphera Pharmaceuticals Inc of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$14.44 ( 1.50%) $14.23

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for DCPH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 15.16 6.56 %
R2 14.89 4.63 %
R1 14.72 3.43 %
Current price: 14.23
Support S1 14.17 -0.434 %
S2 14.00 -1.63 %
S3 13.72 -3.56 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 15.73 10.54 %
R2 15.59 9.56 %
R1 14.39 1.12 %
Current price 14.23
Support S1 14.17 -0.422%
S2 14.02 -1.48%
S3 13.86 -2.60%

FAQ

What is the symbol for Deciphera Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Deciphera Pharmaceuticals Inc is DCPH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Deciphera Pharmaceuticals Inc Stock?
The Deciphera Pharmaceuticals Inc stock holds several negative signals and despite the positive trend, we believe Deciphera Pharmaceuticals Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Deciphera Pharmaceuticals Inc Stock?
Deciphera Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Deciphera Pharmaceuticals Inc Stock.

What's the current price of Deciphera Pharmaceuticals Inc Stock?
As of the end of day on the 2024-04-18, the price of an Deciphera Pharmaceuticals Inc (DCPH) share was $14.23.

What is the 52-week high and low for Deciphera Pharmaceuticals Inc Stock?
The 52-week high for Deciphera Pharmaceuticals Inc Stock is $17.73 and the 52-week low is $9.90.

What is the market capitalization of Deciphera Pharmaceuticals Inc Stock?
As of the 2024-04-18, the market capitalization of Deciphera Pharmaceuticals Inc is 1.189B.

When is the next earnings date for Deciphera Pharmaceuticals Inc?
The upcoming earnings date for Deciphera Pharmaceuticals Inc is May 01, 2024.
Click to get the best stock tips daily for free!

About Deciphera Pharmaceuticals Inc

Deciphera Pharmaceuticals Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. Th... DCPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT